HF
SIOX

HRT Financial’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

HRT Financial’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-17,542
Closed -$89K – 1495
2019
Q4 		$89K Buy
+17,542
New +$97.3K ﹤0.01% 1038
2018
Q3 		– Sell
-1,828
Closed -$33K – 527
2018
Q2 		$33K Buy
+1,828
New +$27K 0.01% 251

Other funds holding SIOX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HRT Financial's SIOX Position: Q1 2020 in Review

HRT Financial sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2020, closing a stake of 17,542 shares — an estimated $89K sold.

HRT Financial first reported a position in SIOX in Q2 2018 and held it in 2 quarters. The position peaked at $89K in Q4 2019. 42 funds tracked by Wall St. Rank hold SIOX as of Q1 2020.

  • HRT Financial reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • HRT Financial sold 17,542 Sio Gene Therapies Inc. Common Stock shares in Q1 2020, an estimated $89K.
  • HRT Financial first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • HRT Financial's Sio Gene Therapies Inc. Common Stock position peaked at $89K in Q4 2019.
  • 42 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2020.

Based on HRT Financial's 13F filing for Q1 2020, filed 15 May 2020.